VITROS CHEMISTRY PRODUCTS VANC REAGENT 6801709

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2019-02-14 for VITROS CHEMISTRY PRODUCTS VANC REAGENT 6801709 manufactured by Ortho-clinical Diagnostics.

Event Text Entries

[138669810] The investigation confirmed that higher than expected vitros vancomycin (vanc) results were obtained from multiple samples collected from the same patient when tested on a vitros 5600 integrated system. The most likely assignable cause of the event is a sample interferent isolated to the affected patient. The patient has an elevated rheumatoid factor (rf) concentration. Representative samples from the patient have been sent to ortho for further investigational testing. The vitros vanc instructions for use does not list rf as an interfering substance. A patient sample correlation, consisting of samples collected from alternate patients, generated concordant results between the vitros and non-vitros (siemens) vancomycin assays, indicating the issue is isolated to the affected patient. There was no indication vitros vanc lot 2514-37-6935 or the vitros 5600 system malfunctioned. Historical quality control results obtained prior to the event were acceptable, indicating the vitros vanc reagent was performing as intended on the vitros 5600 system. Additionally, ongoing tracking and trending of complaint data has not identified any signals to suggest there is a systemic quality issue with vitros vanc lot 2514-37-6935.
Patient Sequence No: 1, Text Type: N, H10


[138669851] A customer obtained higher than expected vitros vancomycin (vanc) results from multiple samples collected from the same patient when tested on a vitros 5600 integrated system. Patient sample 1 results of 30. 2 and 27. 0 ug/ml vs. The expected result of 7. 4 ug/ml. Patient sample 2 result of 27. 1 ug/ml vs. The expected result of 6. 6 ug/ml. Patient sample 3 result of 28. 3 ug/ml vs. The expected result of 7. 4 ug/ml. Patient sample 4 result of 32. 7 ug/ml vs. The expected result of 9. 0 ug/ml. Biased results of the direction and magnitude observed may lead to inappropriate physician action if undetected. The higher than expected vitros vanc results were reported from the laboratory, however a clinician questioned the results. Corrected reports were issued and no allegation of actual patient harm was made. This report corresponds to ortho clinical diagnostics inc (ortho). Complaint numbers (b)(4).
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1319808-2019-00005
MDR Report Key8339291
Date Received2019-02-14
Date of Report2019-03-11
Date of Event2019-01-18
Date Mfgr Received2019-02-15
Device Manufacturer Date2018-08-31
Date Added to Maude2019-02-14
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. JAMES A STEVENS
Manufacturer Street100 INDIGO CREEK DRIVE
Manufacturer CityROCHESTER NY 14626
Manufacturer CountryUS
Manufacturer Postal14626
Manufacturer Phone5854533000
Manufacturer G1ORTHO-CLINICAL DIAGNOSTICS
Manufacturer Street1000 LEE ROAD
Manufacturer CityROCHESTER NY 14606
Manufacturer CountryUS
Manufacturer Postal Code14606
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NameVITROS CHEMISTRY PRODUCTS VANC REAGENT
Generic NameIN-VITRO DIAGNOSTIC
Product CodeLEH
Date Received2019-02-14
Catalog Number6801709
Lot Number2514-37-6935
Device Expiration Date2018-08-31
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerORTHO-CLINICAL DIAGNOSTICS
Manufacturer Address100 INDIGO CREEK DRIVE ROCHESTER NY 14626 US 14626


Patients

Patient NumberTreatmentOutcomeDate
10 2019-02-14

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.